CINEPLEX INC (CGX.CA) Fundamental Analysis & Valuation

TSX:CGX • CA1724541000

Current stock price

11.19 CAD
-0.32 (-2.78%)
Last:

This CGX.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. CGX.CA Profitability Analysis

1.1 Basic Checks

  • CGX had negative earnings in the past year.
  • CGX had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: CGX reported negative net income in multiple years.
  • In the past 5 years CGX always reported a positive cash flow from operatings.
CGX.CA Yearly Net Income VS EBIT VS OCF VS FCFCGX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M -400M -600M

1.2 Ratios

  • CGX's Return On Assets of -1.70% is amongst the best of the industry. CGX outperforms 100.00% of its industry peers.
  • CGX's Return On Invested Capital of 3.97% is amongst the best of the industry. CGX outperforms 88.89% of its industry peers.
  • CGX had an Average Return On Invested Capital over the past 3 years of 4.60%. This is in line with the industry average of 4.69%.
Industry RankSector Rank
ROA -1.7%
ROE N/A
ROIC 3.97%
ROA(3y)1.34%
ROA(5y)-1.55%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)4.6%
ROIC(5y)N/A
CGX.CA Yearly ROA, ROE, ROICCGX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500 -1K -1.5K -2K -2.5K

1.3 Margins

  • CGX has a Operating Margin of 6.97%. This is amongst the best in the industry. CGX outperforms 88.89% of its industry peers.
  • CGX's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 66.70%, CGX belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • CGX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.97%
PM (TTM) N/A
GM 66.7%
OM growth 3Y109.11%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.35%
GM growth 5Y-0.2%
CGX.CA Yearly Profit, Operating, Gross MarginsCGX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

1

2. CGX.CA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CGX is destroying value.
  • The number of shares outstanding for CGX remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for CGX has been increased compared to 5 years ago.
  • Compared to 1 year ago, CGX has a worse debt to assets ratio.
CGX.CA Yearly Shares OutstandingCGX.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
CGX.CA Yearly Total Debt VS Total AssetsCGX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • Based on the Altman-Z score of 0.11, we must say that CGX is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of CGX (0.11) is comparable to the rest of the industry.
  • CGX has a debt to FCF ratio of 19.46. This is a negative value and a sign of low solvency as CGX would need 19.46 years to pay back of all of its debts.
  • With a decent Debt to FCF ratio value of 19.46, CGX is doing good in the industry, outperforming 77.78% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 19.46
Altman-Z 0.11
ROIC/WACC0.49
WACC8.13%
CGX.CA Yearly LT Debt VS Equity VS FCFCGX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 0.52 indicates that CGX may have some problems paying its short term obligations.
  • CGX has a worse Current ratio (0.52) than 66.67% of its industry peers.
  • A Quick Ratio of 0.49 indicates that CGX may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.49, CGX is doing worse than 66.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.52
Quick Ratio 0.49
CGX.CA Yearly Current Assets VS Current LiabilitesCGX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

4

3. CGX.CA Growth Analysis

3.1 Past

  • CGX shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 1.69%.
  • Looking at the last year, CGX shows a decrease in Revenue. The Revenue has decreased by -1.55% in the last year.
  • CGX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 25.16% yearly.
EPS 1Y (TTM)1.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-80%
Revenue 1Y (TTM)-1.55%
Revenue growth 3Y5.22%
Revenue growth 5Y25.16%
Sales Q2Q%-7.71%

3.2 Future

  • CGX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 46.58% yearly.
  • Based on estimates for the next years, CGX will show a small growth in Revenue. The Revenue will grow by 3.09% on average per year.
EPS Next Y167.91%
EPS Next 2Y79.66%
EPS Next 3Y46.58%
EPS Next 5YN/A
Revenue Next Year5.45%
Revenue Next 2Y4.38%
Revenue Next 3Y3.09%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CGX.CA Yearly Revenue VS EstimatesCGX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
CGX.CA Yearly EPS VS EstimatesCGX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 -2 -4 -6

5

4. CGX.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CGX. In the last year negative earnings were reported.
  • CGX is valuated quite expensively with a Price/Forward Earnings ratio of 28.41.
  • Based on the Price/Forward Earnings ratio, CGX is valued cheaper than 88.89% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 21.68. CGX is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 28.41
CGX.CA Price Earnings VS Forward Price EarningsCGX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CGX indicates a somewhat cheap valuation: CGX is cheaper than 77.78% of the companies listed in the same industry.
  • CGX's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CGX is cheaper than 77.78% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.65
EV/EBITDA 9.45
CGX.CA Per share dataCGX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • CGX has a very decent profitability rating, which may justify a higher PE ratio.
  • CGX's earnings are expected to grow with 46.58% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y79.66%
EPS Next 3Y46.58%

0

5. CGX.CA Dividend Analysis

5.1 Amount

  • CGX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

CGX.CA Fundamentals: All Metrics, Ratios and Statistics

CINEPLEX INC

TSX:CGX (4/29/2026, 7:00:00 PM)

11.19

-0.32 (-2.78%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Industry Strength7.87
Industry Growth58.96
Earnings (Last)02-11
Earnings (Next)05-11
Inst Owners23.9%
Inst Owner ChangeN/A
Ins Owners1.92%
Ins Owner ChangeN/A
Market Cap704.97M
Revenue(TTM)1.31B
Net Income(TTM)-37.23M
Analysts76
Price Target12.92 (15.46%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-92.25%
Min EPS beat(2)-94.79%
Max EPS beat(2)-89.71%
EPS beat(4)0
Avg EPS beat(4)-91.65%
Min EPS beat(4)-153.04%
Max EPS beat(4)-29.05%
EPS beat(8)2
Avg EPS beat(8)-90.66%
EPS beat(12)3
Avg EPS beat(12)-479.57%
EPS beat(16)6
Avg EPS beat(16)-314.96%
Revenue beat(2)0
Avg Revenue beat(2)-7.34%
Min Revenue beat(2)-8.87%
Max Revenue beat(2)-5.81%
Revenue beat(4)1
Avg Revenue beat(4)-4.97%
Min Revenue beat(4)-8.87%
Max Revenue beat(4)0.2%
Revenue beat(8)3
Avg Revenue beat(8)-3.13%
Revenue beat(12)6
Avg Revenue beat(12)-2.36%
Revenue beat(16)10
Avg Revenue beat(16)-1.19%
PT rev (1m)0%
PT rev (3m)-11.11%
EPS NQ rev (1m)8.27%
EPS NQ rev (3m)-2.58%
EPS NY rev (1m)0%
EPS NY rev (3m)-48.91%
Revenue NQ rev (1m)6.07%
Revenue NQ rev (3m)1.17%
Revenue NY rev (1m)-0.07%
Revenue NY rev (3m)-2.82%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 28.41
P/S 0.54
P/FCF 7.65
P/OCF 5.01
P/B N/A
P/tB N/A
EV/EBITDA 9.45
EPS(TTM)-0.58
EYN/A
EPS(NY)0.39
Fwd EY3.52%
FCF(TTM)1.46
FCFY13.08%
OCF(TTM)2.23
OCFY19.97%
SpS20.79
BVpS-1.26
TBVpS-11.65
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -1.7%
ROE N/A
ROCE 5.51%
ROIC 3.97%
ROICexc 4.32%
ROICexgc 7.57%
OM 6.97%
PM (TTM) N/A
GM 66.7%
FCFM 7.04%
ROA(3y)1.34%
ROA(5y)-1.55%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)4.6%
ROIC(5y)N/A
ROICexc(3y)4.82%
ROICexc(5y)N/A
ROICexgc(3y)8.26%
ROICexgc(5y)N/A
ROCE(3y)6.39%
ROCE(5y)N/A
ROICexgc growth 3Y121.29%
ROICexgc growth 5YN/A
ROICexc growth 3Y123.69%
ROICexc growth 5YN/A
OM growth 3Y109.11%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.35%
GM growth 5Y-0.2%
F-Score5
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 19.46
Debt/EBITDA 6.81
Cap/Depr 30.36%
Cap/Sales 3.71%
Interest Coverage 0.67
Cash Conversion 56%
Profit Quality N/A
Current Ratio 0.52
Quick Ratio 0.49
Altman-Z 0.11
F-Score5
WACC8.13%
ROIC/WACC0.49
Cap/Depr(3y)37.53%
Cap/Depr(5y)32.96%
Cap/Sales(3y)4.94%
Cap/Sales(5y)5.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-80%
EPS Next Y167.91%
EPS Next 2Y79.66%
EPS Next 3Y46.58%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.55%
Revenue growth 3Y5.22%
Revenue growth 5Y25.16%
Sales Q2Q%-7.71%
Revenue Next Year5.45%
Revenue Next 2Y4.38%
Revenue Next 3Y3.09%
Revenue Next 5YN/A
EBIT growth 1Y4.39%
EBIT growth 3Y120.02%
EBIT growth 5YN/A
EBIT Next Year175.05%
EBIT Next 3Y43.87%
EBIT Next 5Y24.6%
FCF growth 1Y15.73%
FCF growth 3Y40.94%
FCF growth 5YN/A
OCF growth 1Y-13.11%
OCF growth 3Y9.53%
OCF growth 5YN/A

CINEPLEX INC / CGX.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CINEPLEX INC (CGX.CA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to CGX.CA.


What is the valuation status for CGX stock?

ChartMill assigns a valuation rating of 5 / 10 to CINEPLEX INC (CGX.CA). This can be considered as Fairly Valued.


Can you provide the profitability details for CINEPLEX INC?

CINEPLEX INC (CGX.CA) has a profitability rating of 6 / 10.


What is the financial health of CINEPLEX INC (CGX.CA) stock?

The financial health rating of CINEPLEX INC (CGX.CA) is 1 / 10.


Can you provide the expected EPS growth for CGX stock?

The Earnings per Share (EPS) of CINEPLEX INC (CGX.CA) is expected to grow by 167.91% in the next year.